Explore more about: Point of Care Technologies - Diagnostics

NIH announced finalists in its competition to accelerate development of diagnostic and monitoring technologies to improve fetal health outcomes in low-resource settings.

The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services.

Emory University announced on Wednesday that the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health has awarded a team of academic and medical institutions — including Emory University, the Georgia Institute of Technology and Children’s Healthcare of Atlanta — $7.8 million for research. Source: The Atlanta Journal-Constitution

UMass Chan Medical School and UMass Lowell have received $8.9 million from the National Institutes of Health in support for their development of home care technology. Source: Worcester Business Journal

NIH will advance the development of home-based and point-of-care health technologies with awards to six technology research and development centers around the country. The centers comprise the Point of Care Technology Research Network (POCTRN) and will parlay the momentum of the original network established in 2007 by the NIBIB.

The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Fetal Monitoring Challenge calls on scientists, engineers, and clinicians around the country to submit their innovative approaches and compete for prizes and additional resources to support technology development and clinical impact.

Some people using antigen tests have experienced a negative test result only to find out that they have the virus. New research shows that repeat testing every other day increases the detection of the SARS-CoV-2 virus.

New recommendations from the NIH Rapid Acceleration of Diagnostics (RADx®) Tech Program provide a blueprint for the design and manufacture of more accessible diagnostic tests.

NIH has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities.

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.